16th Annual Cardiovascular Update Conference
February 6th and 7th from 8:00 am - 5:00 pm
For details visit: Registration Page

ACC Live Courses
For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings

RSS Latest in Cardiology from ACC.org

  • In Memoriam: ACC Past President Robert L. Frye, MD, MACC
    The ACC mourns the loss of Robert L. Frye, MD, MACC, a distinguished physician, investigator, educator and leader whose career helped shape modern cardiovascular medicine, as well as the College. Frye, who served as ACC President from 1991-1992, leaves behind a legacy of service to patients and the profession spanning more than seven decades.
  • ACC CardiaCast: Risk Assessment and Treatment of Hypertriglyceridemia
    This episode of CardiaCast will feature a discussion on risk assessment and the treatment of hypertriglyceridemia.
  • GBD Study 2023: LDL-C Burden Increasing Globally
    The global burden attributable to elevated LDL-C has grown substantially since 1990, driven largely by population growth and aging despite significant declines in age-standardized rates, according to findings from the Global Burden of Disease Study 2023 (GBD 2023) Cholesterol Collaborators published July 29 in JAMA.
  • MUTTON-HF: Culturally Focused Food is Medicine Intervention Improves CV Outcomes in Navajo Nation
    A culturally and medically tailored Indigenous Food is Medicine meal (CMTM) program reduced hospitalization and emergency department (ED) visits compared with dietary advice alone among patients with heart failure (HF) in Native communities, according to results of the MUTTON-HF trial, published July 27 in JAMA Internal Medicine.
  • SAMCRO: Lifestyle Intervention Improves Angina-Related Health Status in ANOCA
    In patients with invasively confirmed angina with no obstructive coronary artery disease (ANOCA), adding a structured multidomain lifestyle intervention to medical therapy tailored to each patient’s ANOCA endotype led to clinically meaningful improvements in patient-reported health status, according to results from the prospective SAMCRO trial published July 27 in JACC: Cardiovascular Interventions.